VNRX
Volitionrx Ltd
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Volitionrx Ltd
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
—
No other changes.
No other changes.
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
No thesis.
No peers for Volitionrx Ltd yet.
No peers for Volitionrx Ltd yet.
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 31 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
—
Volitionrx Ltd
0.20
—
Linked news
Expected move
No implied move.
| Manager | Value | % base | |
|---|---|---|---|
| Lagoda | $2.0M | 77.30% | new |
| Luminus | $211,811 | 8.33% | new |
| Geodeindex-like | $74,986 | 2.95% | new |
| Vanguardindex-like | $68,423 | 2.69% | new |
| Sontag Advisory | $60,750 | 2.39% | −79.55% |
| Manager | Value | % base | |
|---|---|---|---|
| Lagoda | $2.0M | 77.30% | new |
| Luminus | $211,811 | 8.33% | new |
| Geodeindex-like | $74,986 | 2.95% | new |
| Vanguardindex-like | $68,423 | 2.69% | new |
| Sontag Advisory | $60,750 | 2.39% | −79.55% |
−93.08%
shares held · 8 largest managers